Related Experiment Video
Updated: May 15, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library
Published on: January 10, 2025
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer
Marco Ranzani1, Daniela Cesana, Cynthia C Bartholomae
1San Raffaele-Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.
Abstract:
Transposons and γ-retroviruses have been efficiently used as insertional mutagens in different tissues to identify molecular culprits of cancer. However, these systems are characterized by recurring integrations that accumulate in tumor cells and that hamper the identification of early cancer-driving events among bystander and progression-related events. We developed an insertional mutagenesis platform based on lentiviral vectors (LVVs) by which we could efficiently induce hepatocellular carcinoma (HCC) in three different mouse models. By virtue of the LVV's replication-deficient nature and broad genome-wide integration pattern, LVV-based insertional mutagenesis allowed identification of four previously unknown liver cancer-associated genes from a limited number of integrations. We validated the oncogenic potential of all the identified genes in vivo, with different levels of penetrance. The newly identified genes are likely to play a role in human cancer because they are upregulated, amplified and/or deleted in human HCCs and can predict clinical outcomes of patients.
Insights
Researchers developed a lentiviral vector (LVV) platform for insertional mutagenesis, successfully identifying four novel liver cancer genes. This method overcomes limitations of older systems, aiding early cancer driver event discovery in hepatocellular carcinoma (HCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Insertional mutagenesis using transposons and γ-retroviruses aids cancer gene discovery.
- Recurring integrations in tumor cells complicate the identification of early cancer drivers.
- Existing methods struggle to differentiate early events from bystander or progression-related mutations.
Purpose of the Study:
- To develop a novel insertional mutagenesis platform using lentiviral vectors (LVVs).
- To efficiently induce hepatocellular carcinoma (HCC) in mouse models.
- To identify previously unknown liver cancer-associated genes and validate their oncogenic potential.
Main Methods:
- Developed a lentiviral vector (LVV)-based insertional mutagenesis platform.
- Induced hepatocellular carcinoma (HCC) in three distinct mouse models.
- Analyzed integration patterns and validated identified genes in vivo and in human HCC data.
Main Results:
- The LVV platform efficiently induced HCC across three mouse models.
- Identified four novel genes associated with liver cancer from a limited number of integrations.
- Validated the oncogenic potential of these genes in vivo, showing varying penetrance.
- Confirmed relevance to human HCC, with identified genes showing altered expression, amplification, or deletion, and predicting patient outcomes.
Conclusions:
- LVV-based insertional mutagenesis is a powerful tool for identifying early cancer drivers.
- The identified genes represent novel contributors to liver cancer pathogenesis.
- These findings have implications for understanding and potentially treating human hepatocellular carcinoma.
Related Concept Videos
Non-LTR Retrotransposons
In-vitro Mutagenesis
Mechanisms of Retrovirus-induced Cancers

